Business Context and Reporting Period
Company: TRxADE HEALTH, INC. (formerly Trxade Group, Inc.)
Reporting Date: July 26, 2021
Period Covered: Three and six months ended June 30, 2021
Trading Symbol: MEDS (NASDAQ Capital Market)
Emerging Growth Company: Yes
Key Financial Metrics
This Form 8-K serves as a notification of the issuance of a press release regarding financial results. The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes in financial performance versus prior periods. It indicates that a summary of financial results for the three and six months ended June 30, 2021, was issued via press release and conference call.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The referenced press release contains forward-looking statements regarding future financial performance, events, and trends.
- Risks and Uncertainties: Management notes that actual results may differ materially from projections due to known and unknown risks, uncertainties, and assumptions outside the Company's control.
- Disclaimer: The Company undertakes no obligation to update or revise forward-looking statements after the date of the filing.
- Reference Documents: Detailed risk factors and management discussion are available in the Company's Form 10-K for the year ended December 31, 2021, and Form 10-Q for the quarter ended June 30, 2021.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 26, 2021) for specific revenue, net income, and cash flow figures.
- Verify the Form 10-Q for the quarter ended June 30, 2021, for audited financial statements and detailed MD&A.
- Confirm the Form 10-K for the year ended December 31, 2021, for comprehensive risk factors and annual performance data.
- Check the Company's investor relations website (https://www.trxadegroup.com/investors) for the conference call webcast and transcript.